Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems

The understanding of the impact of COVID‐19 in patients with cancer is evolving, with need for rapid analysis.

[1]  D. Rader,et al.  Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients , 2021, JNCI cancer spectrum.

[2]  Alokkumar Jha,et al.  Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis , 2020, Blood.

[3]  E. Wagner,et al.  The Impact of COVID-19 on African American Communities in the United States , 2020, Health equity.

[4]  A. Hauschild,et al.  Abstract S02-01: Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI) , 2020 .

[5]  V. Abedi,et al.  Racial, Economic, and Health Inequality and COVID-19 Infection in the United States , 2020, Journal of Racial and Ethnic Health Disparities.

[6]  Kathleen M. Akgün,et al.  Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study , 2020, PLoS medicine.

[7]  J. Warner,et al.  LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis , 2020, Annals of Oncology.

[8]  J. Warner,et al.  LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19) , 2020, Annals of Oncology.

[9]  Jessica K De Freitas,et al.  Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19 , 2020, Journal of General Internal Medicine.

[10]  V. Torri,et al.  Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. , 2020 .

[11]  Alokkumar Jha,et al.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.

[12]  Leora I. Horwitz,et al.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.

[13]  Kristen M J Azar,et al.  Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. , 2020, Health affairs.

[14]  J. Wolchok,et al.  Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers , 2020, Cancer discovery.

[15]  E. Robilotti,et al.  Determinants of Severity in Cancer Patients with COVID-19 Illness , 2020, medRxiv.

[16]  C. Beyrer,et al.  Assessing differential impacts of COVID-19 on black communities , 2020, Annals of Epidemiology.

[17]  Shao-bo Shi,et al.  Clinical characteristics and outcomes of cancer patients with COVID‐19 , 2020, Journal of medical virology.

[18]  I. Puzanov,et al.  COVID-19 and Cancer: a Comprehensive Review , 2020, Current Oncology Reports.

[19]  S. Kalnicki,et al.  Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System , 2020, Cancer discovery.

[20]  Laura C Myers,et al.  Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. , 2020, JAMA.

[21]  G. Curigliano,et al.  Effect of the COVID-19 pandemic on cancer treatment and research , 2020, The Lancet Haematology.

[22]  Soumitra Sengupta,et al.  Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series , 2020, medRxiv.

[23]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[24]  H. Miyashita,et al.  Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City , 2020, Annals of Oncology.

[25]  Lynnette Brammer,et al.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[26]  S. Fröhling,et al.  Caring for patients with cancer in the COVID-19 era , 2020, Nature Medicine.

[27]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[28]  M. Santillana,et al.  Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multi-Center Study During the COVID-19 Outbreak , 2020 .

[29]  R. Eggo,et al.  Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[31]  J. Blay,et al.  Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City , 2020 .

[32]  K. Fushimi,et al.  American Journal of Epidemiology Practice of Epidemiology Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data from 6 Countries , 2022 .